Early Detection
Saves Lives
Screen for Early Indicators
of Cancer with HrC Genomics
Early Detection Saves Lives
- Simple Blood Test for Cancer
- Can Detect Absence of Cancer
- Indicates Risk of Cancer Presence
- Annual Screening To Catch Cancer Early
Benefits of HrC Genomics
- Capable of Detecting cancer earlier than MRI, CT & PET Scans
- Minimally Invasive Sample Collection
- Only Requires a 15 Minute Appointment
- Appointments Available Across the UK
Screening with HrC Genomics
- Simple blood test for cancer.
- Samples processed using Next Generation Sequencing (NGS) technology.
- The test measures a marker that is present in all people. As such, we are the only test that determines the likelihood of cancer absence as well as the likelihood of cancer presence.
- Detects early indicators of possible cancer presence which can be monitored through annual testing.
- Capable of detecting risk of cancer presence earlier than any other known technology i.e., MRI, CT, PET and other liquid biopsy technology.
- Has been validated for 60+ cancers including solid tumours, blood cancers and soft tissue sarcomas.
- Can be used to monitor cancer survivors for risk of cancer recurrence.
- Minimally invasive procedure means that the test can be taken as often as required.
- Post-consultation with a healthcare professional may be offered to explain the results.
B3 Onco (Blood Based Biopsy)
B3 Onco provides a Full Cancer Health Check of all the organs. We analyze pluripotent stem cells and progenitors that contain signatures of the organ of origin as well as information relating to the tumour(s) if present i.e., type of cancer, impacted organ/s, altered expressions and dysregulated pathways.
B3 Onco is a simple blood test that provides detailed information that can help guide treatment, for all the organs impacted by cancer, without a tissue biopsy.
Being a simple blood test, B3 Onco can be performed as often as required to help monitor responsiveness to treatment as well as being able provide double confirmation of remission for cancer survivors.
Simple Blood Test, Amazing Results
- Full Cancer Health Check of all major organs.
- Full report issued containing detailed information to assist Oncologist in determine best treatment options.
- Identifies dysregulated pathways and altered gene expressions.
- Works on solid tumours, blood cancers and soft tissue sarcomas.
- Can be used to monitor responsiveness to cancer treatment.
- Can be used for double confirmation of remission in cancer survivors
- Cen be used to provide the underlying systemic malignancy in both symptomatic and asymptomatic patients
- Simple blood test that can be taken as often as necessary unlike tissue biopsies or PET scans.
- Pre-consultation and post-consultation meeting with a healthcare professional included.
Cancer’s unpredictable nature makes it a formidable foe. Early detection is critical for successful treatment and survival, but often, cancer develops silently.
HrC Genomics offers a proactive solution. This technology analyses specific biomarkers in your blood, providing insights into your cancer risk before symptoms appear.
This is especially crucial for individuals at high risk due to family history, exposure to carcinogens (like asbestos or radon), or lifestyle factors like smoking. Understanding your risk empowers you to take action.
Early detection through blood testing allows for timely intervention, significantly improving outcomes and potentially saving lives. It’s a proactive step towards safeguarding your health.
Combo Test
The Combo Test bundle includes both the B3 Onco and HrC Genomics tests.
